Pfizer started 2026 on a high note despite ongoing skepticism from retail investors. Its key anti-cancer drugs, Padcev, Lorbrena, and Talzenna, showed strong performance in Q4. Accordingly, sales of ...
It might be fair to argue that college basketball has never been hotter with both men’s and women’s NCAA Tournament action seeing big ratings numbers. On the men’s side, CBS and TNT Sports’ coverage ...
Verizon's latest quarterly results impressed investors and gave the stock a big boost. While it's up big this year, the stock still trades at an attractive valuation. But despite its strong rally to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results